FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028305184> ?p ?o ?g. }

• W2028305184 abstract "We previously reported satisfactory therapeutic results when using cisplatin-based cyclic balloon-occluded arterial infusion chemotherapy as neoadjuvant chemotherapy (NAC), which enabled hysterectomy to be performed for patients with locally advanced cervical cancer. Mitotic arrest deficiency 2 (MAD2) is a key component of the mitotic spindle checkpoint pathway. The expression of MAD2 is associated with tumor progression and resistance to chemotherapy. Therefore, the aim of the present study was to examine whether the expression of MAD2 is related to the efficacy of NAC for locally advanced uterine cervical cancer. We reviewed 53 cases of locally advanced uterine cervical cancer (stage IIIa-IIIb; based on the International Federation of Gynecology and Obstetrics criteria). These patients were initially treated at Osaka City University Medical School Hospital, Japan, from 1995 to 2008 and were under 70 years old. Tumor samples were obtained by biopsy prior to NAC. Cases were divided into two groups: one group in which NAC was effective, surgery was possible and radiotherapy was performed (NAC+OP+R group; n=33), and another group in which NAC was ineffective and radiation therapy was performed (NAC+R group; n=20). MAD2 expression was examined in paraffin-embedded sections using the avidin-biotin peroxidase complex method. The results showed that MAD2 expression was significantly higher in the NAC+R group compared to the NAC+OP+R group (P<0.001). There was no significant difference in overall survival between the two groups, although the prognosis for the NAC+OP+R group tended to be slightly better (P=0.064). Taken together, these results suggest that the expression of MAD2 may predict the efficacy of NAC as a treatment for locally advanced uterine cervical cancer." @default.
• W2028305184 created "2016-06-24" @default.
• W2028305184 creator A5001196940 @default.
• W2028305184 creator A5002186960 @default.
• W2028305184 creator A5007623110 @default.
• W2028305184 creator A5015074866 @default.
• W2028305184 creator A5019577667 @default.
• W2028305184 creator A5030693722 @default.
• W2028305184 creator A5042218973 @default.
• W2028305184 creator A5054474804 @default.
• W2028305184 creator A5077441314 @default.
• W2028305184 creator A5082008827 @default.
• W2028305184 date "2011-12-05" @default.
• W2028305184 modified "2023-09-28" @default.
• W2028305184 title "Expression of mitotic-arrest deficiency 2 predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer" @default.
• W2028305184 cites W1516287557 @default.
• W2028305184 cites W1520947267 @default.
• W2028305184 cites W1544851750 @default.
• W2028305184 cites W1588019438 @default.
• W2028305184 cites W1659503129 @default.
• W2028305184 cites W1942577196 @default.
• W2028305184 cites W1972271586 @default.
• W2028305184 cites W1973916918 @default.
• W2028305184 cites W1987369248 @default.
• W2028305184 cites W1988078905 @default.
• W2028305184 cites W2013651485 @default.
• W2028305184 cites W2024801263 @default.
• W2028305184 cites W2029874297 @default.
• W2028305184 cites W2030202463 @default.
• W2028305184 cites W2034576012 @default.
• W2028305184 cites W2036622279 @default.
• W2028305184 cites W2052509593 @default.
• W2028305184 cites W2068105015 @default.
• W2028305184 cites W2074654130 @default.
• W2028305184 cites W2075087741 @default.
• W2028305184 cites W2078358000 @default.
• W2028305184 cites W2078423482 @default.
• W2028305184 cites W2080308138 @default.
• W2028305184 cites W2083049266 @default.
• W2028305184 cites W2083643696 @default.
• W2028305184 cites W2090974936 @default.
• W2028305184 cites W2097945491 @default.
• W2028305184 cites W2105912300 @default.
• W2028305184 cites W2106630697 @default.
• W2028305184 cites W2112639278 @default.
• W2028305184 cites W2147246240 @default.
• W2028305184 cites W2150836292 @default.
• W2028305184 cites W2159830370 @default.
• W2028305184 cites W2263001779 @default.
• W2028305184 cites W2324392028 @default.
• W2028305184 cites W2412665662 @default.
• W2028305184 cites W2917216743 @default.
• W2028305184 doi "https://doi.org/10.3892/etm.2011.407" @default.
• W2028305184 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3438618" @default.
• W2028305184 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22969893" @default.
• W2028305184 hasPublicationYear "2011" @default.
• W2028305184 type Work @default.
• W2028305184 sameAs 2028305184 @default.
• W2028305184 citedByCount "9" @default.
• W2028305184 countsByYear W20283051842012 @default.
• W2028305184 countsByYear W20283051842013 @default.
• W2028305184 countsByYear W20283051842014 @default.
• W2028305184 countsByYear W20283051842016 @default.
• W2028305184 countsByYear W20283051842022 @default.
• W2028305184 crossrefType "journal-article" @default.
• W2028305184 hasAuthorship W2028305184A5001196940 @default.
• W2028305184 hasAuthorship W2028305184A5002186960 @default.
• W2028305184 hasAuthorship W2028305184A5007623110 @default.
• W2028305184 hasAuthorship W2028305184A5015074866 @default.
• W2028305184 hasAuthorship W2028305184A5019577667 @default.
• W2028305184 hasAuthorship W2028305184A5030693722 @default.
• W2028305184 hasAuthorship W2028305184A5042218973 @default.
• W2028305184 hasAuthorship W2028305184A5054474804 @default.
• W2028305184 hasAuthorship W2028305184A5077441314 @default.
• W2028305184 hasAuthorship W2028305184A5082008827 @default.
• W2028305184 hasBestOaLocation W20283051841 @default.
• W2028305184 hasConcept C105696609 @default.
• W2028305184 hasConcept C121608353 @default.
• W2028305184 hasConcept C126322002 @default.
• W2028305184 hasConcept C143998085 @default.
• W2028305184 hasConcept C2776694085 @default.
• W2028305184 hasConcept C2777563682 @default.
• W2028305184 hasConcept C2778220009 @default.
• W2028305184 hasConcept C2778239845 @default.
• W2028305184 hasConcept C2778515176 @default.
• W2028305184 hasConcept C29537977 @default.
• W2028305184 hasConcept C71924100 @default.
• W2028305184 hasConceptScore W2028305184C105696609 @default.
• W2028305184 hasConceptScore W2028305184C121608353 @default.
• W2028305184 hasConceptScore W2028305184C126322002 @default.
• W2028305184 hasConceptScore W2028305184C143998085 @default.
• W2028305184 hasConceptScore W2028305184C2776694085 @default.
• W2028305184 hasConceptScore W2028305184C2777563682 @default.
• W2028305184 hasConceptScore W2028305184C2778220009 @default.
• W2028305184 hasConceptScore W2028305184C2778239845 @default.
• W2028305184 hasConceptScore W2028305184C2778515176 @default.
• W2028305184 hasConceptScore W2028305184C29537977 @default.
• W2028305184 hasConceptScore W2028305184C71924100 @default.
• W2028305184 hasLocation W20283051841 @default.
• W2028305184 hasLocation W20283051842 @default.

• next